Building a Broad Portfolio and Making Go-No-Go Decisions

The speakers discuss the advantages of a broad portfolio in regenerative medicine and highlight the use of a hypothesis-driven approach and milestone gating for go-no-go decisions. They also reflect on a past program and discuss their vision for the future direction of the company.